Some pharmacies cut liquid Tamiflu cost
USA Today - 29 minutes agoWalgreens has reduced its prices by nearly 20% and CVS nearly 10% for a scarce liquid form of H1N1 drug Tamiflu amid price-gouging probes.
Food and Drug Administration
4623 Stories, most recent news story added 1 hour 41 minutes ago
News Stories
-
Merck KGaA Shares Slide on FDA Setback for MS Pill (Update2)
Bloomberg - Mon Nov 30, 12:06 pm ETNov. 30 (Bloomberg) -- Merck KGaA fell the most since July in Frankfurt trading after U.S. regulators rejected as incomplete its application to sell the first pill to treat multiple sclerosis.
-
Ibuprofen might help prostate condition
The Charlotte Observer - Mon Nov 30, 8:44 pm ETQ. Have you ever heard of ibuprofen helping men with prostate problems? I am a runner and frequently use ibuprofen after a long run. I discovered that on the days that I took ibuprofen, I didn't have to get up at night to go to the bathroom.
-
FDA approves new vaccine to prevent seasonal flu
WQOW Eau Claire - Mon Nov 30, 5:34 pm ETThe U.S. Food and Drug Administration says it has approved a new vaccine to prevent seasonal influenza.
-
Biotech Stocks: Drug stocks split; Theravance slides on setback
Market Watch - Mon Nov 30, 10:40 am ETShares of Theravance fall on news that U.S. regulators have refused to approve its pneumonia treatment telavancin until they receive more supporting information on the product.
-
Terry Krepel: Swine Flu Scaremongering: How Many People Will WorldNetDaily Kill?
The Huffington Post - 1 hour 41 minutes agoIt's not often that a news organization is determined to kill off its readers, but that's what WorldNetDaily seems to be doing in its wild...
-
Anxious No Longer
The Motley Fool - Mon Nov 30, 3:03 pm ETEli Lilly adds another approval onto Cymbalta.
-
Look Out for Fake H1N1 Cure-all Claims
KOLN Lincoln - 1 hour 48 minutes agoVaccine for the H1N1 Flu is scarce and that has many people looking for alternative ways to stay healthy. But look out, some products falsely claim to prevent or even cure H1N1 and they're feeding off the flu scare.
-
Merck KGaA Shares Slide on FDA Setback for Cladribine MS Pill
Bloomberg - Mon Nov 30, 10:21 am ETNov. 30 (Bloomberg) -- Merck KGaA fell the most since July in Frankfurt trading after U.S. regulators rejected its application seeking approval for what was tipped to be the first pill to treat multiple sclerosis.
-
The FDA Moves the Goalposts
The Motley Fool - Mon Nov 30, 2:33 pm ETTheravance gets its touchdown called back by the regulatory refs.
-
PFC Pharma Joins DATATRAK's CRO Connect Program
redOrbit - Mon Nov 30, 6:15 pm ETCLEVELAND, Nov. 30 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that PFC Pharma Focus AG (PFC) has joined its CRO Connect Program.
-
Ophthalmic Imaging Systems Receives FDA Clearance to Market Revolutionary New Portable Digital Imaging Device
Marketwire - Mon Nov 30, 3:05 pm ETSACRAMENTO, CA--(Marketwire - November 30, 2009) - Ophthalmic Imaging Systems ("OIS" or "the Company") ( OTCBB : OISI ), a leading digital imaging and informatics company, today announced that its revolutionary new portable imaging device, the OIS EyeScan, has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA). The OIS EyeScan is the only portable imaging device ...
-
Cumberland Beats Zacks Estimate
Zacks.com via Yahoo! Finance - Mon Nov 30, 8:02 am ETCumberland Pharmaceuticals reports third quarter earnings comfortably beating the Zacks Consensus Estimate.
-
EMD Serono NDA for MS drug gets FDA refuse-to-file response
Mass High Tech: The Journal of New England Technology - Mon Nov 30, 1:45 pm ETThe U.S. Food and Drug Administration has refused to file a New Drug Application it received from Rockland biopharmaceutical firm EMD Serono Inc. for the company’s Cladribine tablets, an oral drug treatment for relapsing multiple sclerosis.
-
Court hears Vioxx lawsuit arguments
Deseret News - Mon Nov 30, 3:53 pm ETWASHINGTON — Lawyers for Merck & Co. told the Supreme Court Monday investors waited too late and didn't do all of the...
-
2nd UPDATE: Stryker To Buy Ascent Healthcare For $525 Million
Nasdaq - Mon Nov 30, 3:17 pm ET(Adds analysts' comments in final three graphs; Updates share price.)
FDA: Recalls
-
Stryker Corporation’s Instruments Division Issues Worldwide Class 1 Recall of 23 Operating Room System II Surgical Navigation Systems; Catalog numbers 7700-100-000 and 7700-101-201
Wed Nov 25, 3:10 pm EST -
Vita Food Products, Inc. Issues an Alert Announcing Undeclared Wheat in ELF Branded Herring in Sour Cream
Wed Nov 25, 12:44 pm EST -
Timco Worldwide Inc. issuance of a voluntary recall of Large Seedless Watermelons because of possible health risk
Tue Nov 24, 9:11 am EST -
Unilever Issues Nationwide Allergy Alert on Undeclared Sulfites in Certain Shedd’s Country Crock® Chilled Side-Dish Products
Mon Nov 23, 10:26 am EST -
Five Crowns Marketing Voluntarily Recalling Cantaloupes Packed under the Majesty Label Because of a Potential Health Risk Due to Possible Contamination of Salmonella
Fri Nov 20, 6:14 pm EST
Most Blogged About
-
FAA will allow Boeing 777 aircraft with suspect parts to stay aloft
DailyFinance - Mon Nov 30, 5:10 am EST -
YEARS AGO, the FDA shut down sales of a product called Jogging In A Jug. “By law, the product–a mi…
Instapundit - Mon Nov 30, 1:34 pm EST -
Reason TV’s Nanny of the Month: November 2009
Big Government - Mon Nov 30, 11:41 am EST
